Clinical Implications of a Novel, Iron-containing Fiducial Marker in Radiotherapy for Liver Tumors: An Initial Experience

A 0.5%-iron-containing fiducial marker, Gold Anchor(TM) (Naslund Medical AB, Huddinge, Sweden), has been recently developed. Herein, we report our initial experiences with the clinical use of the Gold Anchor(TM )(GA) in radiotherapy for liver tumors. Data of four consecutive patients with liver tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Doi, Hiroshi, Harui, Shogo, Nakajima, Hiroki, Ando, Akira, Kamino, Keiji, Fujiwara, Masayuki, Nakajima, Takayoshi, Ikura, Shinichi, Aihara, Tsukasa, Yamanaka, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794412/
https://www.ncbi.nlm.nih.gov/pubmed/29404229
http://dx.doi.org/10.7759/cureus.1902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794412/
https://www.ncbi.nlm.nih.gov/pubmed/29404229
http://dx.doi.org/10.7759/cureus.1902

Ejemplares similares